Am J Transplant, Volume 18, Suppl 3 Archives - Page 197 of 211 - ATC Abstracts

2018 American Transplant Congress
Kidney and Liver DCD Outcomes – A Five Year Review
J. Buggs,¹ J. Boone,² M. Adesunkanmi,² R. Mehta,² E. Rogers,³ A. Kumar,⁴ A. Alsina,¹ V. Bowers.¹
¹Transplant Surgery, Tampa General Medical Group, Tampa General Hospital, Tampa, FL; ²Pre-Med Undergraduate, University of South Florida, Tampa, FL; ³Transplant Research, Tampa General Hospital, Tampa, FL; ⁴Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL.
Background: The demand for organ transplantation exceeds the supply and has led to an increase in use of donation after cardiac death (DCD) solid organs…
2018 American Transplant Congress
Microbiology and Outcomes of Febrile Neutropenia Episodes after Kidney Transplant
G. Dube, S. Husain, H. Morris, D. Cohen, S. Mohan.
Medicine, Columbia University Medical Center, New York, NY.
Febrile neutropenia (FN) is a common complication in cancer patients receiving chemotherapy. Neutropenia is common after kidney transplant (KT), but little is known about the…
2018 American Transplant Congress
Outcomes of Renal Transplants from Donors with Positive Blood or Urine Cultures
L. Chen,¹ D. Kamiyama,² L. Francalacci,¹ E. Zhu,² M. Donnelley,² N. Clayton,² K. Alman,¹ A. De Mattos,¹ J. Brown.³
¹Transplant Nephrology, UC Davis Medical Center, Sacramento, CA; ²Pharmacy, UC Davis Medical Center, Sacramento, CA; ³Infectious Diseases, UC Davis Medical Center, Sacramento, CA.
OBJECTIVES: To evaluate outcomes in renal transplant recipients who received organs from donors with positive blood or urine cultures.METHODS: We performed a retrospective, single-center study…
2018 American Transplant Congress
Use of Right or Left Kidneys in Living-Donor Kidney Transplantation. Comparative Study of 320 Cases
M. Perosa,¹ J. Branez,¹ H. Noujaim,¹ L. Mota,¹ B. Zeballos,¹ M. Castro,¹ G. Marchini,¹ L. Ianhez,¹ L. Alvim,¹ D. Machado,¹ C. Watanabe,¹ A. Saldanha,² H. Abensur,² W. Luconi,¹ T. Genzini-Miranda,³ R. Haddad,⁴ T. Genzini.¹
¹Leforte Hospital, Sao Paulo, Brazil; ²Beneficencia Portuguesa Hospital, Sao Paulo, Brazil; ³Medical School, PUC Sorocaba, Sorocaba, Sao Paulo, Brazil; ⁴Medical School, ABC, Sao Paulo, Brazil.
In more than 95% of worldwide living-donor kidney transplants(LDKT), the donor's left kidney (LK) is preferred because of technical difficulties and a shorter vein of…
2018 American Transplant Congress
Clinically Relevant Variation of Donor-Derived Cell-Free DNA during Longitudinal Surveillance of Renal Allografts
M. Narayanan,¹ T. Alhamad,² D. Hiller,³ J. Yee,³ R. Woodward,³ J. Bromberg.⁴
¹Texas A&M Health Science Center, Temple, TX; ²Washington University School of Medicine, St. Louis, MO; ³CareDx, Brisbane, CA; ⁴University of Maryland School of Medicine, Baltimore, MD.
Purpose: Donor-derived cell-free DNA (dd-cfDNA) levels >1% are associated with active rejection in renal transplant recipients. This report defines the clinically relevant variation of dd-cfDNA…
2018 American Transplant Congress
Derivation and Prospective External Validation of Prediction Models for Acute Kidney Injury in Adult Liver Transplant Recipients
Q. Zhao,¹ Z. Guo,¹ M. Chen,¹ S. Ma,¹ J. Lin,⁴ C. Zhang,² M. Han,³ X. He.¹
¹Organ Transplant Center, The First Affiliated Hospital of Sun Yet-sen University, Guangzhou, China; ²Department of Hepatobiliary Surgery, Guangdong General Hospital, Guangzhou, China; ³Organ Transplant Department, The Eastern Hospital of the First Affiliated Hospital of SYSU, Guangzhou, China; ⁴Department of Hepatobiliary Surgery, The Third People's Hospital of Shenzhen, Shenzhen, China.
BACKGROUND: Acute kidney injury (AKI) is common in patients after liver transplantation, and has a marked impact on the perioperative and long-term morbidity and mortality.…
2018 American Transplant Congress
Surgical Technique and Outcomes of Portal Vein Reconstruction of Adult-to-Adult Living Donor Liver Transplantation Recipients with Portal Vein Thrombosis
N. Kuriyama, A. Hayasaki, T. Fujii, Y. Iizawa, H. Kato, Y. Murata, A. Tanemura, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, H. Sakurai, S. Isaji.
Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
Objectives: Portal vein (PV) reconstruction is a crucial factor for successful living donor liver transplantation (LDLT). Portal vein thrombosis (PVT) remains a critical problem in…
2018 American Transplant Congress
A Comparison of the Discard Rate in Hepatitis C Deceased Liver Donors between Two Eras, 2008-2013 and 2014-2017. A Single Organ Procurement Organization Experience
M. Nazzal,¹ G. Marklin,² O. Okoye,¹ Y. Kim,¹ R. Ouseph.¹
¹Abdominal Transplant, Saint Louis University, Saint Louis, MO; ²Mid America Transplant, Saint Louis, MO.
With the introduction of new hepatitis C medications in 2014 , there is a growing concern for an increase in the discard rate of hepatitis…
2018 American Transplant Congress
Corner-Saving Renal Artery Anastomosis for Renal Transplantation
A. Akdur,¹ M. Kus,² G. Moray,¹ S. Yildirim,¹ F. Yarbug Karakayali,³ K. Caliskan,² M. Haberal.¹
¹Transplantation, Baskent University, Ankara, Turkey; ²Transplantation, Baskent University, Adana, Turkey; ³Transplantation, Baskent University, Istanbul, Turkey.
Introduction: Renal transplantation is the preferred treatment for most patients with end-stage renal disease. Postoperative vascular complications that significantly affect graft loss include renal artery…
2018 American Transplant Congress
Bone Marrow Derived Myeloid Suppressor Cell (BM-MDSCs) Prolongs the Graft Survival in Murine Heart Transplantation
K. Uchida, K. Fujimoto, K. Takeda, H. Bashuda, E. Yin, K. Okumura.
Atopy(Allergy) Research Center, Juntento University, Tokyo, Japan.
Purpose: To investigate the impact of BM-MDSCs on murine heart transplantationMaterial and Methods:Bone marrow cells were harvested and cultured with granulocyte-macrophage colony-stimulating factor (GM-CSF) and…